Human Acellular Vessel (HAV)

· Humacyte, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Human Acellular Vessel (HAV), covering 2023-12-19 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis [Phase 3]